Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
06/27/2012 | CN102512407A Application of utilizing beta-phenylalanine compounds as aldose reductase inhibitors |
06/27/2012 | CN102512403A Application of honokiol in pharmacy, and medicine used for treating type II diabetes mellitus |
06/27/2012 | CN102512398A Simvastatin osmotic pump preparation and preparation method thereof |
06/27/2012 | CN102512393A Oral disintegrated tablet containing tolvaptan |
06/27/2012 | CN102512390A Repaglinide drop pill and preparation method thereof |
06/27/2012 | CN102512388A Glimepiride orally disintegrating medicine composition |
06/27/2012 | CN102512322A Health-care traditional Chinese medicine brewing can placed in boiled water faucet |
06/27/2012 | CN102511568A Fat adjusting hypnotic health care oil |
06/27/2012 | CN102228444B N(2)-L-alanyl-L-glutamine preparation for injection and preparation method thereof |
06/27/2012 | CN102160648B Rapidly disintegrating calcium tablets and preparation method thereof |
06/27/2012 | CN102133187B Pravastatin sodium liposome solid preparation |
06/27/2012 | CN102106927B Fat-clearing pressure-reducing tea |
06/27/2012 | CN102078365B Soft capsule with auxiliary function of reducing blood fat and preparation method thereof |
06/27/2012 | CN102058515B Solid dispersion of 24-methylene cycloartanol ferulic acid eater and preparation thereof |
06/27/2012 | CN102010387B Method for purifying orlistat |
06/27/2012 | CN101972333B Medicament for eliminating turbid urines |
06/27/2012 | CN101972255B Rosiglitazone hydrochloride-containing pharmaceutical composition and preparation method thereof |
06/27/2012 | CN101967123B 2-cyclopropyl-4-(N-methyl substituted anilino) quinoline compound as well as intermediate, preparation method and application thereof |
06/27/2012 | CN101953887B Medicinal composition for preventing and treating diabetic complications and preparation method thereof |
06/27/2012 | CN101947284B Traditional Chinese medicinal composition for treating diabetes and preparation method thereof |
06/27/2012 | CN101913583B Method for extracting chondroitin, collagen and high-calcium powder from animal cartilage |
06/27/2012 | CN101912565B Turmeric and astragalus capsules for treating diabetes and incipient diabetic nephropathy |
06/27/2012 | CN101884678B Pure Chinese medicinal composition for treating metabolic syndrome and pure Chinese medicinal preparation prepared from same |
06/27/2012 | CN101874832B Wine-steamed Chinese goldthread processed product as well as preparation method and application thereof |
06/27/2012 | CN101870671B Adamantly pyrrolidine derivative, and preparation and application thereof |
06/27/2012 | CN101856367B Preparation method of chicken bone paste zymolyte with antioxidant activity |
06/27/2012 | CN101850039B Composition with auxiliary lipid-lowering function |
06/27/2012 | CN101850031B Pueraria isoflavone capsule |
06/27/2012 | CN101804077B Pretreatment method of propolis effective component raw material by supercritical extraction |
06/27/2012 | CN101791332B Compound gingko health product solid preparation |
06/27/2012 | CN101775020B Poly-substituted chromone pyrrole compound and synthetic method and application thereof |
06/27/2012 | CN101744938B Pharmaceutical composition and preparation method thereof |
06/27/2012 | CN101735977B In vitro screening and amplification technology of mouse pancreatic stem/progenitor cells |
06/27/2012 | CN101732330B Phtneolamine mesilate and fructose composition, preparation method thereof and use thereof |
06/27/2012 | CN101628070B Chinese yam polysaccharides extract and preparation method and application thereof |
06/27/2012 | CN101613679B Rhabdovirus with recombination superoxide dismutase gene and preparation and application thereof |
06/27/2012 | CN101602685B Calcium-glutamate chelate synthesis method using shellfish processing waste as calcium source |
06/27/2012 | CN101595096B Substituted carbinol compound |
06/27/2012 | CN101563330B Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators |
06/27/2012 | CN101503399B C-aryl glucoside SGLT2 inhibitor |
06/27/2012 | CN101485885B Protein phosphatase PPM1E used as target for treating disease as well as use thereof and siRNA |
06/27/2012 | CN101433329B Nutritive composition with health-care function |
06/27/2012 | CN101375927B Pharmaceutical combination for preventing birth-defect and improving memory |
06/27/2012 | CN101374833B Novel pyrone-indole derivatives and process for their preparation |
06/27/2012 | CN101366831B Rhubarb polyoses, preparation method, medicament composition and uses |
06/27/2012 | CN101366772B Medicament composition for preventing birth defection and improving memory |
06/27/2012 | CN101322552B Food prescription for regulating blood sugar and processing technique thereof |
06/27/2012 | CN101292726B Method for preparing gold needle mushroom canned food for decreasing blood sugar and adjusting blood fat |
06/27/2012 | CN101254248B Applications of Chinese medicinal composition for preparing medicament for curing chronic fatigue syndrome medicament |
06/27/2012 | CN101242833B Pyrrolopyridine derivatives and use of same as PPAR receptor modulators |
06/27/2012 | CN101156680B Food composition of nourishing blood anti-senescence and method for producing same |
06/27/2012 | CN101133790B Wilding synthesized five kinds of grain, pine nut compressed granules orange juice beverage and method of processing the same |
06/27/2012 | CN101133789B Wilding mineral composition corn, various grains, mountain wild fruits compressed granules and orange juice and method of processing the same |
06/27/2012 | CN101133787B Wilding synthesized black rice black soya bean compressed food granules beverage and method of processing the same |
06/27/2012 | CN101032562B Health care product having functions of conditioning blood pressure and protecting haemal system of heart and brain |
06/26/2012 | USRE43497 Anti-MIF antibodies |
06/26/2012 | US8207227 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
06/26/2012 | US8207196 Compositions and methods for the treatment of metabolic disorders |
06/26/2012 | US8207194 Compounds having a 4-pyridylalkylthio group as a substituent |
06/26/2012 | US8207168 Pyridazinone derivatives |
06/26/2012 | US8207161 Tetrahydro-imidazo[1,5-α]pyrazine derivatives, preparation process and medicinal use thereof |
06/26/2012 | US8207158 5HT2c receptor modulators |
06/26/2012 | US8207140 Oligomeric compounds for the modulation of HIF-1α expression |
06/26/2012 | US8206947 Human transmembrane proteins |
06/26/2012 | US8206739 Fish protein hydrolyzate |
06/26/2012 | US8206719 KDR peptides and vaccines comprising the same |
06/26/2012 | US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa |
06/26/2012 | US8206708 Vascular endothelial growth factor 2 |
06/26/2012 | CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor |
06/26/2012 | CA2554493C Bicycloester derivative |
06/26/2012 | CA2443857C Bisphosphonate conjugates and methods of making and using the same |
06/21/2012 | WO2012082947A1 Compounds and compositions as tgr5 agonists |
06/21/2012 | WO2012082921A1 Cellular activation insulin therapy |
06/21/2012 | WO2012081736A1 Continuous arycyclic compound |
06/21/2012 | WO2012081713A1 Therapeutic agent for blood-brain barrier disruption syndrome |
06/21/2012 | WO2012081676A1 Oxidation reaction product of hop extract, process for production thereof, and use thereof |
06/21/2012 | WO2012081675A1 Hops oxidation product, and production method and use therefor |
06/21/2012 | WO2012081604A1 Composition containing orotic acid, and process for production thereof |
06/21/2012 | WO2012081570A1 Lactam compound or a salt thereof, and ppar activator |
06/21/2012 | WO2012081563A1 Benzothiazole and azabenzothiazole derivative having endothelial lipase inhibitory activity |
06/21/2012 | WO2012080976A1 Lar protein-specific ligand |
06/21/2012 | WO2012080831A1 Composition for the treatment of metabolic disorders |
06/21/2012 | WO2012080555A1 Hydroxytyrosol ethers |
06/21/2012 | WO2012080500A1 Serum amyloid p protein |
06/21/2012 | WO2012080476A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases |
06/21/2012 | WO2012080471A1 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid |
06/21/2012 | WO2012080371A1 New thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders |
06/21/2012 | WO2012080362A1 Preparation comprising insulin, nicotinamide and an amino acid |
06/21/2012 | WO2012080333A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof |
06/21/2012 | WO2012080320A1 Fast-acting insulin in combination with long-acting insulin |
06/21/2012 | WO2012079721A1 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them |
06/21/2012 | WO2012079310A1 Sea cucumber compound preparation and preparation method thereof |
06/21/2012 | WO2012079203A1 Puerarin hydrates, preparation methods and uses thereof |
06/21/2012 | WO2012055967A3 Treating diabetes melitus using insulin injections administered with varying injection intervals |
06/21/2012 | WO2012054376A3 Metal ion nanoclusters |
06/21/2012 | WO2012051107A3 Niacin formulations and methods with reduced flushing side-effect |
06/21/2012 | WO2012027555A3 Glycated cd59 peptides, their preparation, and uses thereof |
06/21/2012 | WO2011084456A9 Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases |
06/21/2012 | US20120157539 Nuclear receptor binding agents |
06/21/2012 | US20120157533 Magnesium Compositions and Uses Thereof for Metabolic Disorders |